ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
0.00%
Bitcoin
67,058.75
0.18%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Alimera Sciences Inc (ALIM)

  7. Alimera Sciences Inc (ALIM) News

ALIM

Alimera Sciences (ALIM)

Alimera Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALIM
DateTimeSourceHeadlineSymbolCompany
17/05/202407:06Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ALIMAlimera Sciences Inc
15/05/202407:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALIMAlimera Sciences Inc
14/05/202422:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
14/05/202421:30GlobeNewswire Inc.Alimera Sciences Reports First Quarter 2024 ResultsNASDAQ:ALIMAlimera Sciences Inc
07/05/202422:00GlobeNewswire Inc.Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress ConferencesNASDAQ:ALIMAlimera Sciences Inc
30/04/202422:00GlobeNewswire Inc.Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate UpdateNASDAQ:ALIMAlimera Sciences Inc
20/03/202423:00GlobeNewswire Inc.Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
19/03/202423:00GlobeNewswire Inc.Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina NetworkNASDAQ:ALIMAlimera Sciences Inc
09/03/202409:23Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
08/03/202400:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
07/03/202423:30GlobeNewswire Inc.Alimera Sciences Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:ALIMAlimera Sciences Inc
01/03/202400:00GlobeNewswire Inc.Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate UpdateNASDAQ:ALIMAlimera Sciences Inc
14/02/202408:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
14/02/202408:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
14/02/202407:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ALIMAlimera Sciences Inc
10/02/202409:25Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
10/02/202409:14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALIMAlimera Sciences Inc
10/02/202409:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
09/02/202400:00GlobeNewswire Inc.The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®NASDAQ:ALIMAlimera Sciences Inc
12/01/202404:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
05/01/202408:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
05/01/202408:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
05/01/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
05/01/202400:00GlobeNewswire Inc.Alimera Completes Recruitment for the Synchronicity StudyNASDAQ:ALIMAlimera Sciences Inc
03/01/202400:00GlobeNewswire Inc.Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
14/12/202309:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
14/12/202309:19Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
13/12/202309:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALIMAlimera Sciences Inc
12/12/202323:30GlobeNewswire Inc.Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ALIMAlimera Sciences Inc
29/11/202308:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALIMAlimera Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:ALIM

Your Recent History

USOTC
RLBY
Reliability (PK)
COIN
ANFDETH
Angry Doge
COIN
BORAETH
BORA
NYSE
FSBD
Fidelity Merrima
NYSE
PLD-M.CL
NYSE
C-K
Citigroup
AMEX
GSJY
Goldman Sachs ActiveBeta...
EU
I010T
I010T
LSE
RT58
Sg Issuer 32
BIT
ESPY
L&GEm Cyber Security ESC...
LBNK
METALINKUSDT
MetaLink
USOTC
NNOCF
Nanoco (PK)
NYSE
STZ.B
Constellation Brands
BITMOT
844331
Romania Tf 3,375% Fb38 Eur
CSE
SBD
SBD Capital
LSE
BG11
Nat.gas.t Fri29
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved